You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 95 No. 6, JUNE 1955 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (15)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Regurgitation Type of Jaundice During Prolonged Therapy with Chlorpromazine

R. E. LEMIRE, Jr., M.D.; R. A. MITCHELL, M.D.

AMA Arch Intern Med. 1955;95(6):840-845.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The appearance of jaundice following the administration of chlorpromazine (Thorazine) has been mentioned rarely in the literature.* Owing to the brief period in which this drug has been used, only a few patients with jaundice have been appraised regarding abnormal liver-function tests, systemic manifestations, course, duration, and prognosis. Therefore three cases of prolonged obstructive type of jaundice which were observed complicating therapy with this drug in three Omaha hospitals are reported below. —Mrs. S. S., a 65-year-old white woman, was hospitalized on Feb. 11, 1954, with a diagnosis of postinvolutional depression. She had been a diabetic for 15 years, well-controlled with diet and insulin. There was no history of allergy or of liver or biliary tract disease. Examination on admission was noncontributory. She received electrical shock therapy followed by chlorpromazine, receiving a total of 3360 mg., the highest daily dosage being 200 mg. On the 23rd day of drug therapy . . . [Full Text PDF of this Article]


Author Affiliations

Omaha

From the Departments of Medicine, Veterans Administration Hospital, University of Nebraska College of Medicine, and Creighton University School of Medicine, and the Department of Medicine, Veterans Administration Hospital; Instructor in Medicine, University of Nebraska College of Medicine and Creighton University School of Medicine (Dr. Lemire), and Resident in Internal Medicine, University of Nebraska College of Medicine (Dr. Mitchell).


Footnotes

Read before the Mid-West Section of the American Federation for Clinical Research, Chicago, Oct. 28, 1954.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1955 American Medical Association. All Rights Reserved.